In primary and secondary tumours of bone, tumour cells can induce sensory and sympathetic nerve endings to grow into the tumour tissue via the nerve growth factor-TrkA signalling pathway, leading to cancer-associated osteodynia (Yang et al., 2024; Yoneda et al., 2023). This evidence concerns the gene NGF and neoplasm.